Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines.
作者信息
Bozkurt Biykem
机构信息
Winters Center for Heart Failure Research, Cardiovascular Research Institute, Baylor College of Medicine, DeBakey VA Medical Center, Houston TX.
出版信息
Circulation. 2023 Mar 14;147(11):877-880. doi: 10.1161/CIRCULATIONAHA.123.063396. Epub 2023 Feb 16.
Abstract
摘要
相似文献
1
Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines.揭示新冠病毒mRNA疫苗引发心肌炎的机制
Circulation. 2023 Mar 14;147(11):877-880. doi: 10.1161/CIRCULATIONAHA.123.063396. Epub 2023 Feb 16.
2
Myocarditis After BNT162b2 and mRNA-1273 Vaccination.接种 BNT162b2 和 mRNA-1273 后心肌炎。
Circulation. 2021 Aug 10;144(6):506-508. doi: 10.1161/CIRCULATIONAHA.121.055913. Epub 2021 Jun 16.
3
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.信使核糖核酸新冠疫苗接种后心肌炎风险的Meta分析
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
4
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
5
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.SARS-CoV-2 感染和 mRNA COVID-19 疫苗接种后的心脏并发症 - PCORnet，美国，2021 年 1 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1.
6
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.mRNA COVID-19 疫苗接种后的心脏并发症：病例报告和病例系列的系统评价。
Rev Med Virol. 2022 Jul;32(4):e2318. doi: 10.1002/rmv.2318. Epub 2021 Dec 17.
7
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测：多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
8
Public Interest in Myocarditis during the SARS-CoV-2 Pandemic.公众对 SARS-CoV-2 大流行期间心肌炎的关注。
Disaster Med Public Health Prep. 2023 Mar 13;17:e349. doi: 10.1017/dmp.2022.307.
9
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
10
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.2019冠状病毒病mRNA疫苗接种后确诊的急性心肌炎
Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4.
引用本文的文献
1
Myocarditis Associated with COVID-19 Vaccination.与新冠病毒疫苗接种相关的心肌炎
Vaccines (Basel). 2024 Oct 19;12(10):1193. doi: 10.3390/vaccines12101193.
2
The impact of COVID-19 status and vaccine type following the first dose on acute heart disease: A nationwide retrospective cohort study in South Korea.新冠肺炎（COVID-19）状态和首剂疫苗类型对急性心脏病的影响：韩国全国回顾性队列研究。
Epidemiol Infect. 2024 Oct 24;152:e134. doi: 10.1017/S0950268824001213.
3
Current landscape of mRNA technologies and delivery systems for new modality therapeutics.新型治疗模式的 mRNA 技术和递送系统的现状。
J Biomed Sci. 2024 Sep 10;31(1):89. doi: 10.1186/s12929-024-01080-z.
4
Humoral and Cellular Response Induced by Primary Series and Booster Doses of mRNA Coronavirus Disease 2019 Vaccine in Patients with Cardiovascular Disease: A Longitudinal Study.2019冠状病毒病mRNA疫苗初免系列和加强剂量在心血管疾病患者中诱导的体液和细胞反应：一项纵向研究
Vaccines (Basel). 2024 Jul 17;12(7):786. doi: 10.3390/vaccines12070786.
5
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.心肌炎后何时、为何以及如何重新挑战氯氮平治疗精神分裂症。
CNS Drugs. 2024 Sep;38(9):671-696. doi: 10.1007/s40263-024-01100-4. Epub 2024 Jul 1.
6
The complexity of cardiovascular long COVID: where we are.心血管长期新冠的复杂性：我们目前的状况
Cardiovasc Res. 2024 Jul 2;120(8):e30-e32. doi: 10.1093/cvr/cvae090.
7
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.一种针对奥密克戎的、自我扩增的 COVID-19 mRNA 加强疫苗：一项 2/3 期随机试验。
Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18.
8
mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions.mRNA-LNP COVID-19 疫苗脂质诱导补体激活和促炎细胞因子的产生：机制、补体抑制剂的作用及与不良反应的相关性。
Int J Mol Sci. 2024 Mar 22;25(7):3595. doi: 10.3390/ijms25073595.
9
SARS-CoV-2 Spike Protein Stimulates Macropinocytosis in Murine and Human Macrophages via PKC-NADPH Oxidase Signaling.严重急性呼吸综合征冠状病毒2刺突蛋白通过蛋白激酶C-烟酰胺腺嘌呤二核苷酸磷酸氧化酶信号传导刺激小鼠和人类巨噬细胞的巨吞饮作用。
Antioxidants (Basel). 2024 Jan 30;13(2):175. doi: 10.3390/antiox13020175.
10
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign.新冠病毒mRNA疫苗：注册试验和全球疫苗接种运动的经验教训
Cureus. 2024 Jan 24;16(1):e52876. doi: 10.7759/cureus.52876. eCollection 2024 Jan.
本文引用的文献
1
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis.新冠病毒 mRNA 疫苗心肌炎患者循环 Spike 蛋白的检测。
Circulation. 2023 Mar 14;147(11):867-876. doi: 10.1161/CIRCULATIONAHA.122.061025. Epub 2023 Jan 4.
2
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险：按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
3
Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination.接种疫苗后15天可在血液中检测到疫苗mRNA。
Biomedicines. 2022 Jun 28;10(7):1538. doi: 10.3390/biomedicines10071538.
4
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis.COVID-19 mRNA 疫苗的不良反应：刺突假说。
Trends Mol Med. 2022 Jul;28(7):542-554. doi: 10.1016/j.molmed.2022.04.007. Epub 2022 Apr 21.
5
Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis.接种 COVID-19 疫苗和非 COVID-19 疫苗后的心肌炎：系统评价和荟萃分析。
Lancet Respir Med. 2022 Jul;10(7):679-688. doi: 10.1016/S2213-2600(22)00059-5. Epub 2022 Apr 11.
6
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.与 COVID-19 疫苗接种或 SARS-CoV-2 感染相关的心肌炎、心包炎和心律失常风险。
Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.
7
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.抗独特型抗体在SARS-CoV-2感染和疫苗接种中的潜在作用。
N Engl J Med. 2022 Jan 27;386(4):394-396. doi: 10.1056/NEJMcibr2113694. Epub 2021 Nov 24.
8
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.SARS-CoV-2 刺突蛋白通过 CD147 受体介导的信号通路破坏人类心脏周细胞功能：COVID-19 微血管疾病的一种潜在非感染性机制。
Clin Sci (Lond). 2021 Dec 22;135(24):2667-2689. doi: 10.1042/CS20210735.
9
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森（强生）疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.
10
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.BNT162b2 mRNA 新冠疫苗在全国范围内使用的安全性。
N Engl J Med. 2021 Sep 16;385(12):1078-1090. doi: 10.1056/NEJMoa2110475. Epub 2021 Aug 25.
Zotero 插件